vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and DORIAN LPG LTD. (LPG). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $120.0M, roughly 1.5× DORIAN LPG LTD.). DORIAN LPG LTD. runs the higher net margin — 39.3% vs 0.9%, a 38.4% gap on every dollar of revenue. On growth, DORIAN LPG LTD. posted the faster year-over-year revenue change (48.7% vs 23.7%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -7.9%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Dorian LPG Ltd. is a leading international shipping company focused on the seaborne transportation of liquefied petroleum gas (LPG). It owns and operates a modern fleet of very large gas carriers, serving energy and petrochemical industry clients across key markets including North America, Asia and Europe.
FOLD vs LPG — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $120.0M |
| Net Profit | $1.7M | $47.2M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 42.8% |
| Net Margin | 0.9% | 39.3% |
| Revenue YoY | 23.7% | 48.7% |
| Net Profit YoY | -88.5% | 120.9% |
| EPS (diluted) | $0.00 | $1.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $120.0M | ||
| Q3 25 | $169.1M | $124.1M | ||
| Q2 25 | $154.7M | $84.2M | ||
| Q1 25 | $125.2M | $75.9M | ||
| Q4 24 | $149.7M | $80.7M | ||
| Q3 24 | $141.5M | $82.4M | ||
| Q2 24 | $126.7M | $114.4M | ||
| Q1 24 | $110.4M | $141.4M |
| Q4 25 | $1.7M | $47.2M | ||
| Q3 25 | $17.3M | $55.4M | ||
| Q2 25 | $-24.4M | $10.1M | ||
| Q1 25 | $-21.7M | $8.1M | ||
| Q4 24 | $14.7M | $21.4M | ||
| Q3 24 | $-6.7M | $9.4M | ||
| Q2 24 | $-15.7M | $51.3M | ||
| Q1 24 | $-48.4M | $79.2M |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | 42.8% | ||
| Q3 25 | 20.3% | 47.8% | ||
| Q2 25 | -6.1% | 18.5% | ||
| Q1 25 | -6.3% | 19.4% | ||
| Q4 24 | 10.7% | 29.0% | ||
| Q3 24 | 15.3% | 23.2% | ||
| Q2 24 | 11.8% | 48.5% | ||
| Q1 24 | -25.1% | 58.3% |
| Q4 25 | 0.9% | 39.3% | ||
| Q3 25 | 10.2% | 44.6% | ||
| Q2 25 | -15.8% | 12.0% | ||
| Q1 25 | -17.3% | 10.7% | ||
| Q4 24 | 9.8% | 26.5% | ||
| Q3 24 | -4.8% | 11.4% | ||
| Q2 24 | -12.4% | 44.9% | ||
| Q1 24 | -43.9% | 56.0% |
| Q4 25 | $0.00 | $1.11 | ||
| Q3 25 | $0.06 | $1.30 | ||
| Q2 25 | $-0.08 | $0.24 | ||
| Q1 25 | $-0.07 | $0.17 | ||
| Q4 24 | $0.05 | $0.50 | ||
| Q3 24 | $-0.02 | $0.22 | ||
| Q2 24 | $-0.05 | $1.25 | ||
| Q1 24 | $-0.16 | $1.96 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $294.5M |
| Total DebtLower is stronger | $392.7M | $513.2M |
| Stockholders' EquityBook value | $274.2M | $1.1B |
| Total Assets | $949.9M | $1.8B |
| Debt / EquityLower = less leverage | 1.43× | 0.47× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $294.5M | ||
| Q3 25 | $263.8M | $268.3M | ||
| Q2 25 | $231.0M | $277.9M | ||
| Q1 25 | $250.6M | $316.9M | ||
| Q4 24 | $249.9M | $314.5M | ||
| Q3 24 | $249.8M | $348.6M | ||
| Q2 24 | $260.1M | $353.3M | ||
| Q1 24 | $239.6M | $282.5M |
| Q4 25 | $392.7M | $513.2M | ||
| Q3 25 | $392.0M | $526.4M | ||
| Q2 25 | $391.3M | $539.6M | ||
| Q1 25 | $390.7M | $553.3M | ||
| Q4 24 | $390.1M | $565.9M | ||
| Q3 24 | $389.5M | $579.0M | ||
| Q2 24 | $388.9M | $592.1M | ||
| Q1 24 | $388.4M | $605.1M |
| Q4 25 | $274.2M | $1.1B | ||
| Q3 25 | $230.4M | $1.1B | ||
| Q2 25 | $204.3M | $1.0B | ||
| Q1 25 | $193.6M | $1.0B | ||
| Q4 24 | $194.0M | $1.1B | ||
| Q3 24 | $178.8M | $1.1B | ||
| Q2 24 | $132.5M | $1.1B | ||
| Q1 24 | $130.7M | $1.0B |
| Q4 25 | $949.9M | $1.8B | ||
| Q3 25 | $868.8M | $1.8B | ||
| Q2 25 | $815.3M | $1.7B | ||
| Q1 25 | $789.8M | $1.8B | ||
| Q4 24 | $785.0M | $1.8B | ||
| Q3 24 | $786.6M | $1.9B | ||
| Q2 24 | $749.5M | $1.9B | ||
| Q1 24 | $721.8M | $1.8B |
| Q4 25 | 1.43× | 0.47× | ||
| Q3 25 | 1.70× | 0.49× | ||
| Q2 25 | 1.92× | 0.52× | ||
| Q1 25 | 2.02× | 0.53× | ||
| Q4 24 | 2.01× | 0.53× | ||
| Q3 24 | 2.18× | 0.53× | ||
| Q2 24 | 2.93× | 0.53× | ||
| Q1 24 | 2.97× | 0.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $80.8M |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | 1.71× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $80.8M | ||
| Q3 25 | $35.7M | $46.4M | ||
| Q2 25 | $-26.5M | $814.5K | ||
| Q1 25 | $7.8M | $50.2M | ||
| Q4 24 | $-3.9M | $24.3M | ||
| Q3 24 | $-23.0M | $57.3M | ||
| Q2 24 | $22.7M | $41.2M | ||
| Q1 24 | $-29.7M | $154.2M |
| Q4 25 | $16.0M | — | ||
| Q3 25 | $35.3M | — | ||
| Q2 25 | $-28.9M | — | ||
| Q1 25 | $7.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-23.3M | — | ||
| Q2 24 | $21.6M | — | ||
| Q1 24 | $-31.5M | — |
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.9% | — | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | -16.5% | — | ||
| Q2 24 | 17.0% | — | ||
| Q1 24 | -28.5% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 9.62× | 1.71× | ||
| Q3 25 | 2.06× | 0.84× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 6.20× | ||
| Q4 24 | -0.27× | 1.14× | ||
| Q3 24 | — | 6.08× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
LPG
Segment breakdown not available.
